| Trial ID: | L0811 |
| Source ID: | NCT06406140
|
| Associated Drug: |
Niacin Tablets 500 Mg
|
| Title: |
Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
ENROLLING_BY_INVITATION
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-stage Renal Disease
|
| Interventions: |
DRUG: Niacin tablets 500 mg
|
| Outcome Measures: |
Primary: Change in serum phosphorus level, Niacin is expected to lower serum phosphorus levels in dialysis patients, 3 months | Secondary: change in Lipoprotein (a) Concentration, Lipoprotein (a) , which has been suggested to play a role as an independent risk factor for coronary heart disease, is expected to be decreased by niacin, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Al-Azhar University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-03-15
|
| Completion Date: |
2026-02-15
|
| Results First Posted: |
|
| Last Update Posted: |
2025-01-31
|
| Locations: |
Al Azhar University, Cairo, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT06406140
|
